Most people understand that spotlight deficit and disorder disorder syndrome (ADHD) is characterised by inability to concentrate, excessive thoughtlessness, disorder and anxiety. The attention deficit disorder identification will solely be confirmed if the activity disorders are discovered throughout long amount of your time. Usually, ADHD develops in childhood (in children of 3 to 6 years old). Still, there is a chance that symptoms of this behavioral disorder may occur in children, later observed in teenagers and adults.
It were yankee scientists, United Nations agency have claimed that attention deficit disorder could be a neurobehavioral disorder. Therefore particularly the USA was the country that developed special standards to diagnose the attention deficit disorder. These standards were represented on public in “Diagnostic and Statistical Manual of Mental Disorders”.
This manual states that so as to diagnose attention deficit disorder in childhood, one ought to essentially contemplate the amount of physical, emotional, mental and social development of a toddler. Mandatory point is monitoring of child’s behavior in different situations, including: home, school and relationships with friends.
There are three types of ADHD:
* ADHD with predominant attention deficit;
* ADHD with predominant hyperactivity and impulsiveness;
* combined ADHD, including all the listed symptoms
The attention deficit disorder medical aid involves a fancy approach: psycho-educational medical aid and drug medical aid. For better control over the ADHD symptoms, the FDA has approved two types of ADHD meds: the CNS stimulants and non-stimulant agents.
Regardless of the type of ADHD meds, these drugs can be prescribed for patients over 6 years old only. An overwhelming majority of individuals, ar counseled to start the activity disorder medical aid with attention deficit disorder meds that stimulate the system.
* CNS stimulants and ADHD treatment
Usually doctors bring down ADD meds, containing active substance, known as Ritalin. On pharmaceutical market, these ADD meds ar on the market below the trade names: Concerta, APO-Methylphenidate, Daytrana, Biphentin, Metadate, PMS-Methylphenidate, Methylin, PHL-Methylphenidate and stimulant.
The length of pharmacologic impact of the listed ADD meds depends on the dose forms (tablets, capsules, solution, suspension and patch). Therapeutic impact of those ADD meds is achieved by increasing the monoamine neurotransmitter neurotransmitters within the brain, influencing on the mental activity, attention and motivation.
* Non-stimulant agents and ADHD treatment
The first non-stimulant ADHD medication was norepinephrine reuptake inhibitor Atomoxetine. The CNS norepinephrine controls the activity of brain receptors, regulating the speed of reaction, attention and impulsiveness.
Non-stimulant ADHD meds are prescribed in case the CNS stimulants do not provide the expected therapeutic effect, or if person is contraindicated to use medications, stimulating the CNS.
Unlike the CNS stimulants, non-stimulant ADHD meds never cause the drug dependence in patients. The truth is that each one medications, poignant the system (ADHD meds included) will stimulate mental and (or) physical addiction. Therefore ADD meds that stimulate the system can not be prescribed for patients, who have or have had alcohol and (or) drug addiction.
It is additionally necessary that failure to suits dose plan of ADD meds worsens the management over the ADD symptoms. Because once person misses a dose of ADD meds, the behavioral disorder symptoms become worse, therefore effectiveness of ADHD medical treatment decreases.
But if person abuses ADD meds, he might become tolerant to their therapeutic properties. So, further use of ADHD meds becomes impractical. That is why one should take every other dose of ADHD meds at one and the same time and observe the daily dose the doctor prescribed.